RxDoctor Payments Data

Benjamin Epstein

Physician Assistant · Davidson, NCNPI 1205295409

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 39.6% of the total. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$447,320in general payments, 2019–2025

Across 2,278 payments — averaging $196.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$177K
  • AbbVie$104K
  • Alkermes, Inc.$75K
  • Collegium Pharmaceutical, Inc.$19K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$16K
  • Idorsia Pharmaceuticals US Inc$13K
  • plus $44K from 32 others

What the payments were for

  • Consulting fees$126,59628%
  • Speaking & faculty fees$224,03350%
  • Travel & lodging$62,55114%
  • Food & beverage$34,0498%
  • Education$910%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$447,320 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate22$173,747
VraylarCariprazine Hcl46$100,302
TrintellixVortioxetine Hydrobromide35$42,557
AuvelityDextromethorphan Hbr/Bupropion19$37,573
LybalviOlanzapine/Samidorphan Malate12$34,218
Aripiprazole68$15,230
VyvanseLisdexamfetamine Dimesylate23$8,760
Lurasidone Hcl14$8,559
Dyanavel XrAmphetamine13$5,560
Adderall XrDextroamphetamine/Amphetamine13$5,079
Vilazodone Hcl26$4,885
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$2,676
Desvenlafaxine Succinate ErDesvenlafaxine Succinate25$2,569
Bupropion XlBupropion Hcl86$1,983
Duloxetine Hcl58$1,732

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$3,054$173,74722 claims
AbbVieVraylar$103,842$100,30246 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$769$51,31658 claims
Axsome Therapeutics, Inc.Auvelity$177,133$37,57319 claims
Alkermes, Inc.Lybalvi$74,825$34,21812 claims
Tris Pharma IncDyanavel Xr$195$5,56013 claims
Lilly USA, LLCOlanzapine$17$76622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Davidson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →